Clinical trial
Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm With Micropapillary and Solid Subtype Positive by Frozen Section: A Prospective, Observational, Multicenter Cohort Study
NCT05838053 is registered in ClinicalTrials.gov with Shanghai Pulmonary Hospital, Shanghai, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Segmentectomy Versus Lobectomy for Lung Adenocarcinoma ≤ 2cm With Micropapillary and Solid Subtype Positive by Frozen Section: A Prospective, Observational, Multicenter Cohort Study
- Lead sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 20, 2019
- Completion date
- April 30, 2028
- Enrollment
- 446 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung adenocarcinoma